Latest News Archive

Please select Category, Year, and then Month to display items

Fighting COVID-19: Here is how we are helping

16 April 2020 | Story Department of Communication and Marketing | Photo Charl Devenish

Farmovs — In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe.

The University of the Free State (UFS) is committed to supporting government’s efforts to overcome the COVID-19 pandemic. During this challenging time, dedicated staff members at the UFS continue to provide services as a testimony to their commitment to advance public knowledge of COVID-19 for the greater good of South Africa.

The following is a synopsis of the areas in which the UFS is actively assisting.

Public Health Emergency Solidarity Trial
Clinicians from the Department of Internal Medicine, the Department of Critical Care, and the Division of Virology will be working with FARMOVS to participate in the Public Health Emergency Solidarity Trial initiated by the World Health Organization (WHO). This international randomised trial will evaluate four treatment options (remdesivir, lopinavir/ritonavir, lopinavir/ritonavir plus interferon, chloroquine or hydroxychloroquine) for the treatment of COVID-19.

The trial is expected to include more than 45 countries worldwide, including a number of South African sites.

Farmovs
FARMOVS is in a planning process to support all the Bloemfontein hospitals, including Pelonomi, Universitas, 3 Military Hospital, Mediclinic, and Rosepark, in conducting the largest global trial on COVID-19 – the Public Health Emergency Solidarity Trial, under leadership of the WHO.

Negotiations are ongoing between the UFS and the Department of Health in the Free State for FARMOVS to offer support with the continuation of healthcare to non-COVID-19 patients in an attempt to free up space at Universitas Hospital for isolation of COVID-19 patients.

In 2019, FARMOVS was pre-qualified by the WHO to support clinical studies aimed at improving access to quality generic medicines across the globe. FARMOVS also receives feasibility requests for support with the evaluation of existing drugs (repurposing) as well as the development of novel drugs for the treatment of COVID-19 – this is an ongoing process.

Disaster Management Training and Education Centre (DiMTEC)
DiMTEC represents the UFS on the Provincial Joint Operation Centre (PROVJOC). The PROVJOC is a fully equipped, dedicated facility that is proactively established to enable all relevant role players /disciplines to jointly manage all safety and security-related aspects of any planned event or any major incident which has occurred or is imminent – especially in the response and recovery operations phase – at the strategic and/or tactical level, using the Unified Command System. This facility is also linked to all other established safety and security centres.

Research and Innovation
The UFS hosts a SARChI Research Chair in vector-borne and zoonotic diseases, and recently invested in the establishment of a biosafety level-3 facility. Hence, there is expertise on the campus to plan and conduct research on zoonotic and medically significant viruses. In addition, there are research groups focusing on protein expression systems with potential for utilisation in the development of diagnostic assays with application in either diagnosis or surveillance.

Currently, researchers at the UFS have established several projects that will contribute directly towards the COVID-19 outbreak.

News Archive

Miss South Africa is a Kovsie

2014-03-31

Rolene Strauss
Images: www.facebook.com/#!/MsSouthAfrica

“Rolene Strauss is an example of physical beauty, academic excellence and public duty coming together in one person,” said Prof Jansen.

Twenty-one-year-old Rolene Strauss, a third-year medical student at the University of the Free State (UFS), was crowned as Miss South Africa at a gala event at Sun City the weekend. Rolene was also the favourite on Twitter.

In her acceptance speech, Rolene said that she dearly loves South Africa. “This is where I can live, speak, learn and love freely. This is where my dreams come true. I am very proud of our country and shall always have a purpose here. It is such a privilege to represent our wonderful country. Our future is bright and I can’t wait to represent South Africa nationally and internationally,” Rolene said.

“My passion for health will definitely form a big part of my year, together with the initiatives of the sponsors,” she said.

Rolene said that Prof Jonathan Jansen, the Vice-Chancellor and Rector of the UFS, is an inspiration to her. “He stands up for what he believes in and enjoys what he is doing. He wants the best for his students and supports them in everything they do,” she said.

“Thanks to the support of the UFS and Prof Jansen, I am able to stop my studies for a year and continue after my Miss South Africa year. I am who I am today because of the people around me – and that definitely includes Kovsies. I see the university as a garden in which I can flower,” she said.

The university community is very proud of Rolene, and it is confirmed by Prof Jansen. “I am extremely proud of Rolene Strauss, for she has proved that physical beauty, academic excellence and public duty can come together in one person, and offer a powerful platform for transforming communities in need that would otherwise remain invisible, were it not for such a wonderful young role model,” he said.

On the year which lies ahead, Rolene said: “It will be a year during which I shall give back, say thank you and be a good example of the potential that especially women and South Africans may have in our country.”

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept